Which Pharmaceutical Better, VanEck's PPH or Invesco's PJP?
Choosing the right pharmaceutical ETF can feel like balancing income with growth. This guide compares VanEck's PPH an...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesChoosing the right pharmaceutical ETF can feel like balancing income with growth. This guide compares VanEck's PPH an...
As SpaceX eyes a historic float, investors are handed a high-stakes mix of dream-scale growth and sobering risk. This...
Top-tier buyers are steering a different cycle as higher rates soften the broader market. Wealth migration and long-t...
When a market giant bets on housing, investors notice. This article dives into Berkshire Hathaway's $6.8 billion move...
Two Kalshi veterans are raising up to $35 million for a new prediction-market VC fund called 5c(c) Capital, backed by...
SpaceX rockets higher after announcing a $60 billion all-stock purchase of Cursor AI, lifting its market cap above $2...
The Department of Justice confirmed an active antitrust inquiry into the U.S. beef industry, targeting major meatpack...
Rising private valuations for SpaceX are fueling chatter about a Tesla takeover. Market participants say the odds spa...
Crypto traders are pricing SpaceX ahead of any IPO using Hyperliquid's SPCX-USDC contract, with early data suggesting...
A wave of selective rallies in WLD, XLM, and JTO underscores a fragile altcoin bounce. Analysts say hype is waning, w...
Jennifer Lopez re-listed the Beverly Hills mansion she once co-owned, trimming the asking price as the luxury real es...
A rare volatility split signals risk concentrated in tech names. Analysts caution that this is a warning, not a crash...